Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
A Multi-center, Open-label, Four-arm, Randomized Trial Evaluating the Safety and Tolerability of Brivaracetam Intravenous Infusion and Bolus, Administered in BID Regimen as an Adjunctive Antiepileptic Treatment in Subjects From 16 to 70 Years Suffering From Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2285
mi
from 98109
Charlottesville, VA
Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
A Multi-center, Open-label, Four-arm, Randomized Trial Evaluating the Safety and Tolerability of Brivaracetam Intravenous Infusion and Bolus, Administered in BID Regimen as an Adjunctive Antiepileptic Treatment in Subjects From 16 to 70 Years Suffering From Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2285
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
A Multi-center, Open-label, Four-arm, Randomized Trial Evaluating the Safety and Tolerability of Brivaracetam Intravenous Infusion and Bolus, Administered in BID Regimen as an Adjunctive Antiepileptic Treatment in Subjects From 16 to 70 Years Suffering From Epilepsy
Status: Enrolling
Updated:  12/31/1969
Investigator Site 102
mi
from 98109
Brno,
Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
A Multi-center, Open-label, Four-arm, Randomized Trial Evaluating the Safety and Tolerability of Brivaracetam Intravenous Infusion and Bolus, Administered in BID Regimen as an Adjunctive Antiepileptic Treatment in Subjects From 16 to 70 Years Suffering From Epilepsy
Status: Enrolling
Updated: 12/31/1969
Investigator Site 102
mi
from 98109
Brno,
Click here to add this to my saved trials
Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite
An Open Label, Single-dose, Fixed Sequence, Two Treatment Period Study to Assess the Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR).
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1392
mi
from 98109
Minneapolis, MN
Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite
An Open Label, Single-dose, Fixed Sequence, Two Treatment Period Study to Assess the Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR).
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1392
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
766
mi
from 98109
Fresno, CA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
766
mi
from 98109
Fresno, CA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
942
mi
from 98109
Oxnard, CA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
942
mi
from 98109
Oxnard, CA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
626
mi
from 98109
Sacramento, CA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
626
mi
from 98109
Sacramento, CA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2543
mi
from 98109
Bradenton, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2543
mi
from 98109
Bradenton, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2485
mi
from 98109
Ocala, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2485
mi
from 98109
Ocala, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2281
mi
from 98109
Panama City, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2281
mi
from 98109
Panama City, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2527
mi
from 98109
Tampa, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2686
mi
from 98109
Wellington, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2686
mi
from 98109
Wellington, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1939
mi
from 98109
Louisville, KY
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1939
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2056
mi
from 98109
Hammond, LA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2056
mi
from 98109
Hammond, LA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2338
mi
from 98109
Waldorf, MD
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2338
mi
from 98109
Waldorf, MD
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1386
mi
from 98109
Golden Valley, MN
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1386
mi
from 98109
Golden Valley, MN
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1634
mi
from 98109
Springfield, MO
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1634
mi
from 98109
Springfield, MO
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
396
mi
from 98109
Missoula, MT
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
396
mi
from 98109
Missoula, MT
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2375
mi
from 98109
Camden, NJ
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2375
mi
from 98109
Camden, NJ
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2298
mi
from 98109
Greensboro, NC
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2298
mi
from 98109
Greensboro, NC
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2052
mi
from 98109
Canton, OH
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2052
mi
from 98109
Canton, OH
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2004
mi
from 98109
Columbus, OH
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2004
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1961
mi
from 98109
Dayton, OH
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1961
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1439
mi
from 98109
Lubbock, TX
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1439
mi
from 98109
Lubbock, TX
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1616
mi
from 98109
Madison, WI
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1681
mi
from 98109
Milwaukee, WI
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1681
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2038
mi
from 98109
Huntsville, AL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2038
mi
from 98109
Huntsville, AL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
984
mi
from 98109
Orange, CA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2588
mi
from 98109
Port Charlotte, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2588
mi
from 98109
Port Charlotte, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2554
mi
from 98109
Sarasota, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2554
mi
from 98109
Sarasota, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2041
mi
from 98109
Akron, OH
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2041
mi
from 98109
Akron, OH
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
104
7364
mi
from 98109
Chatswood,
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
104
7364
mi
from 98109
Chatswood,
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2338
mi
from 98109
Durham, NC
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2338
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1769
mi
from 98109
Austin, TX
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1769
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
960
mi
from 98109
Los Angeles, CA
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
960
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2206
mi
from 98109
Gulf Breeze, FL
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2206
mi
from 98109
Gulf Breeze, FL
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2589
mi
from 98109
Port Charlotte, FL
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2589
mi
from 98109
Port Charlotte, FL
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2687
mi
from 98109
Wellington, FL
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2687
mi
from 98109
Wellington, FL
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1400
mi
from 98109
Saint Paul, MN
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1400
mi
from 98109
Saint Paul, MN
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1874
mi
from 98109
Memphis, TN
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1874
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1675
mi
from 98109
Dallas, TX
Study in Pediatric Subjects With Epilepsy
Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1675
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Buspirone Therapy for Localized Epilepsy
A Phase Two Clinical Trial of Buspirone Therapy in Localization-Related Epilepsy
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Buspirone Therapy for Localized Epilepsy
A Phase Two Clinical Trial of Buspirone Therapy in Localization-Related Epilepsy
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2005
mi
from 98109
Lexington, KY
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2005
mi
from 98109
Lexington, KY
Click here to add this to my saved trials
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2041
mi
from 98109
Akron, OH
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2041
mi
from 98109
Akron, OH
Click here to add this to my saved trials
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1782
mi
from 98109
Little Rock, AR
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2400
mi
from 98109
New York, NY
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials